Global Information
회사소개 | 문의

세계의 혈액 관련 의약품 시장 : 혈액 제품, 빈혈용 의약품, 기타 혈액질환용 의약품

Hematology Drugs Global Market Report 2019

리서치사 The Business Research Company
발행일 2019년 01월 상품 코드 531329
페이지 정보 영문 300 Pages
가격
US $ 4,000 ₩ 4,527,000 PDF by E-mail (Single User License)
US $ 6,000 ₩ 6,790,000 PDF by E-mail (Site License)
US $ 8,000 ₩ 9,054,000 PDF by E-mail (Enterprise License)


세계의 혈액 관련 의약품 시장 : 혈액 제품, 빈혈용 의약품, 기타 혈액질환용 의약품 Hematology Drugs Global Market Report 2019
발행일 : 2019년 01월 페이지 정보 : 영문 300 Pages

이 페이지에 게재되어 있는 내용은 최신판과 약간 차이가 있을 수 있으므로 영문목차를 함께 참조하여 주시기 바랍니다. 기타 자세한 사항은 문의 바랍니다.

세계의 혈액 관련 의약품 시장을 조사했으며, 시장 정의와 개요, 시장에 대한 각종 영향요인 분석, 약제 부문·지역·국가별 동향과 시장 규모 추이 및 예측, 거시경제 요인·헬스케어 시장 전체·각종 산업 지표와의 비교, 경쟁 환경, 기업 개요 등을 정리하여 전해드립니다.

제1장 시장의 특징

제2장 시장 규모·성장률

  • 시장 성장 : 현재까지의 경위
    • 성장 촉진요인
    • 성장 억제요인
  • 시장 성장 : 예측
    • 성장 촉진요인
    • 성장 억제요인

제3장 PESTLE 분석

제4장 고객 정보

제5장 혈액 관련 의약품 시장 분석 : 세분화별

  • 세계 시장의 실적 : 부문별
    • 혈액 제품
    • 빈혈용 의약품
    • 기타 혈액질환용 의약품
  • 세계 시장의 추이와 예측 : 부문별
  • 시장 동향·전략

제6장 혈액 관련 의약품 시장 분석 : 지역·국가별 분석

  • 세계 시장의 실적 : 지역별
  • 세계 시장의 추이와 예측 : 지역별
  • 시장 실적 : 국가별
  • 시장의 추이와 예측 : 국가별
  • 세계 의약품 시장의 실적 : 부문·지역별
  • 세계 의약품 시장의 실적 : 부문·국가별

제7장 거시경제 요인과 시장의 비교

  • 시장 규모의 GDP에서 차지하는 비율
  • 1인당 평균 지출액

제8장 거시경제 요인과 시장의 비교 : 국가별

  • 시장 규모의 GDP에서 차지하는 비율 : 국가별
  • 1인당 평균 지출액 : 국가별

제9장 산업 지표와 시장의 비교

  • 세계의 약제사 수 : 국가별
  • 시장 매출 vs 약제사 수 : 국가별
  • 세계의 의약품회사 수 : 국가별
  • 시장 매출 vs 의약품회사 수 : 국가별
  • 세계의 R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 시장 매출 vs R&D/제품 개발에 대한 평균 지출액 : 국가별
  • 세계의 제네릭 & 브랜드 매출 비율 : 국가별
  • 시장 매출 vs 제네릭 & 브랜드 매출 비율 : 국가별
  • 탈라세미아 환자 수 : 국가별

제10장 아시아태평양 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 중국
  • 인도
  • 일본
  • 호주

제11장 서유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인

제12장 동유럽 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 러시아

제13장 북미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 미국

제14장 남미 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별
  • 국가별 분석
  • 브라질

제15장 중동 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제16장 아프리카 시장

  • 시장 개요
  • 시장의 과거 추이
  • 시장 예측
  • 시장 실적 : 부문별

제17장 경쟁 환경

  • 기업 개요
  • Baxalta
  • Bayer Ag
  • Novo Nordisk
  • Pfizer Inc.
  • Biogen Idec

제18장 주요 M&A : 혈액 관련 의약품 시장

제19장 시장 배경 : 의약품 시장

제20장 의약품 산업의 파이낸셜 마진

제21장 부록

KSA 17.08.07

Hematology Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global hematology drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the hematology drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Hematology Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The hematology drugs market section of the report gives context. It compares the hematology drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, hematology drugs indicators comparison.

Scope

Markets Covered: Blood Products, Anemia And Other Blood Disorder Drugs

Companies Mentioned: Novo Nordisk A/S, Shire Plc, Bayer AG, Daiichi Sankyo Company, Biogen Inc

Metrics Covered: Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, hematology drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Hematology Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Hematology Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Hematology Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Hematology Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Hematology Drugs Market Trends And Strategies

8. Hematology Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Hematology Drugs Market Regional Analysis

  • 9.1. Global Hematology Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Hematology Drugs Market, Growth And Market Share Comparison, By Region

10. Hematology Drugs Market Segmentation

  • 10.1. Global Hematology Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Blood Products
    • 10.1.2. Anemia And Other Blood Disorder Drugs

11. Hematology Drugs Market Metrics

  • 11.1. Hematology Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Hematology Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Hematology Drugs Market

  • 12.1. Asia-Pacific Hematology Drugs Market Overview
  • 12.2. Asia-Pacific, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Hematology Drugs Market Metrics
    • 12.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
  • 12.6. Asia-Pacific Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Hematology Drugs Market: Country Analysis
    • 12.7.1. China Hematology Drugs Market
      • 12.7.1.1. China Hematology Drugs Market Overview
      • 12.7.1.2. China Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Hematology Drugs Market
      • 12.7.2.1. Australia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Hematology Drugs Market
      • 12.7.3.1. Hong Kong Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Hematology Drugs Market
      • 12.7.4.1. India Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Hematology Drugs Market
      • 12.7.5.1. Indonesia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Hematology Drugs Market
      • 12.7.6.1. Japan Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Hematology Drugs Market
      • 12.7.7.1. Malaysia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Hematology Drugs Market
      • 12.7.8.1. New Zealand Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Hematology Drugs Market
      • 12.7.9.1. Philippines Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Hematology Drugs Market
      • 12.7.10.1. Singapore Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Hematology Drugs Market
      • 12.7.11.1. South Korea Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Hematology Drugs Market
      • 12.7.12.1. Thailand Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Hematology Drugs Market
      • 12.7.13.1. Vietnam Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Hematology Drugs Market

  • 13.1. Western Europe Hematology Drugs Market Overview
  • 13.2. Western Europe, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Hematology Drugs Market Metrics
    • 13.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Western Europe Countries
  • 13.6. Western Europe Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Hematology Drugs Market: Country Analysis
    • 13.7.1. Austria Hematology Drugs Market
      • 13.7.1.1. Austria Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Hematology Drugs Market
      • 13.7.2.1. Belgium Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Hematology Drugs Market
      • 13.7.3.1. Denmark Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Hematology Drugs Market
      • 13.7.4.1. Finland Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Hematology Drugs Market
      • 13.7.5.1. France Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Hematology Drugs Market
      • 13.7.6.1. Germany Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Hematology Drugs Market
      • 13.7.7.1. Ireland Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Hematology Drugs Market
      • 13.7.8.1. Italy Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Hematology Drugs Market
      • 13.7.9.1. Netherlands Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Hematology Drugs Market
      • 13.7.10.1. Norway Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Hematology Drugs Market
      • 13.7.11.1. Portugal Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Hematology Drugs Market
      • 13.7.12.1. Spain Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Hematology Drugs Market
      • 13.7.13.1. Sweden Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Hematology Drugs Market
      • 13.7.14.1. Switzerland Hematology Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Hematology Drugs Market
      • 13.7.15.1. UK Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Hematology Drugs Market

  • 14.1. Eastern Europe Hematology Drugs Market Overview
  • 14.2. Eastern Europe, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Hematology Drugs Market Metrics
    • 14.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
  • 14.6. Eastern Europe Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Hematology Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Hematology Drugs Market,
      • 14.7.1.1. Czech Republic Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Hematology Drugs Market
      • 14.7.2.1. Poland Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Hematology Drugs Market
      • 14.7.3.1. Romania Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Hematology Drugs Market
      • 14.7.4.1. Russia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Hematology Drugs Market

  • 15.1. North America Hematology Drugs Market Overview
  • 15.2. North America, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Hematology Drugs Market Metrics
    • 15.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, North America Countries
  • 15.6. North America Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Hematology Drugs Market: Country Analysis
    • 15.7.1. Canada Hematology Drugs Market
      • 15.7.1.1. Canada Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Hematology Drugs Market
      • 15.7.2.1. Mexico Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Hematology Drugs Market
      • 15.7.3.1. USA Hematology Drugs Market Overview
      • 15.7.3.2. USA Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Hematology Drugs Market

  • 16.1. South America Hematology Drugs Market Overview
  • 16.2. South America, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Hematology Drugs Market Metrics
    • 16.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, South America Countries
  • 16.6. South America Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Hematology Drugs Market: Country Analysis
    • 16.7.1. Argentina Hematology Drugs Market
      • 16.7.1.1. Argentina Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Hematology Drugs Market
      • 16.7.2.1. Brazil Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Hematology Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Hematology Drugs Market
      • 16.7.3.1. Chile Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Hematology Drugs Market
      • 16.7.4.1. Colombia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Hematology Drugs Market
      • 16.7.5.1. Peru Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Hematology Drugs Market
      • 16.7.6.1. Venezuela Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Hematology Drugs Market

  • 17.1. Middle East Hematology Drugs Market Overview
  • 17.2. Middle East, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Hematology Drugs Market Metrics
    • 17.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Middle East Countries
  • 17.6. Middle East Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Hematology Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Hematology Drugs Market
      • 17.7.1.1. Saudi Arabia Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Hematology Drugs Market
      • 17.7.2.1. Israel Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Hematology Drugs Market
      • 17.7.3.1. Turkey Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Hematology Drugs Market
      • 17.7.4.1. UAE Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Hematology Drugs Market

  • 18.1. Africa Hematology Drugs Market Overview
  • 18.2. Africa, Hematology Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Hematology Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Hematology Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Hematology Drugs Market Metrics
    • 18.5.1. Per Capita Average Hematology Drugs Expenditure, 2014 - 2022, Africa Countries
  • 18.6. Africa Hematology Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Hematology Drugs Market: Country Analysis
    • 18.7.1. Egypt Hematology Drugs Market
      • 18.7.1.1. Egypt Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Hematology Drugs Market
      • 18.7.2.1. Nigeria Hematology Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Hematology Drugs Market
      • 18.7.3.1. South Africa Hematology Drugs Market, 2014 - 2022, Value ($ Billion)

19. Hematology Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Novo Nordisk A/S
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.1.3. Company Hematology Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. Shire Plc
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.2.3. Company Hematology Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Bayer AG
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.3.3. Company Hematology Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Daiichi Sankyo Company
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.4.3. Company Hematology Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Biogen Inc
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Hematology Drugs Market Structure And Strategy
      • 19.3.5.3. Company Hematology Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Hematology Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Hematology Drugs Market In 2022- Growth Countries
  • 22.2. Global Hematology Drugs Market In 2022- Growth Segments
  • 22.3. Global Hematology Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top
전화 문의
이용안내
 
BCC Research